Showing results (121-130 of 174) with videos related to
Sort By:
Pageof 18
The Lancet. HIV|March 20, 2019
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trialFrances H Priddy, David J M Lewis, Huub C Gelderblom, et al.Frontiers in Immunology|March 8, 2021
Utilizing Computational Machine Learning Tools to Understand Immunogenic Breadth in the Context of a CD8 T-Cell Mediated HIV ResponseEd McGowan, Rachel Rosenthal, Andrew Fiore-Gartland, et al.Frontiers in Immunology|March 29, 2021
A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 InfectionJulia Makinde, Eunice W Nduati, Anna Freni-Sterrantino, et al.Viruses|January 27, 2021
HIV-1 Gag-Pol Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication CapacityAnne Kapaata, Sheila N Balinda, Rui Xu, et al.Journal of Translational Medicine|April 14, 2011
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010Sarah Brinckmann, Kelly da Costa, Marit J van Gils, et al.Virus Evolution|January 21, 2026
Single genome amplification and molecular cloning of HIV-1 populations in acute HIV-1 infection: implications for studies on HIV-1 diversity and evolutionary rateAnthony Y Y Hsieh, Amin S Hassan, Jamirah Nazziwa, et al.Viruses|February 26, 2022
Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006-2011)Sheila N Balinda, Anne Kapaata, Rui Xu, et al.Clinical and Vaccine Immunology : CVI|January 25, 2013
Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adultsPeter Hayes, Jill Gilmour, Andrea von Lieven, et al.The Journal of Experimental Medicine|August 24, 2016
Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progressionDaniela C Mónaco, Dario A Dilernia, Andrew Fiore-Gartland, et al.Plos One|August 8, 2015
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African AdultsJuliet Mpendo, Gaudensia Mutua, Julien Nyombayire, et al.Pageof 18